STAAR Surgical Co
Income Statement
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93.5M | $93.5M | $57.8M | $94.7M | $44.3M | $42.6M | $49.0M | $88.6M |
| Cost of Revenue | $23.8M | $24.7M | $14.1M | $16.9M | $11.5M | $14.6M | $17.3M | $20.1M |
| Gross Profit | $69.7M | $68.9M | $43.7M | $77.9M | $32.8M | $28.0M | $31.6M | $68.5M |
| Gross Margin | 74.5% | 73.6% | 75.7% | 82.2% | 74.0% | 65.8% | 64.7% | 77.3% |
| Operating Expenses | ||||||||
| Research & Development | $9.9M | $9.9M | $9.2M | $9.2M | $10.3M | $11.3M | $7.8M | $12.2M |
| SG&A Expense | $59.6M | $60.9M | $66.6M | $59.4M | $62.8M | $85.4M | $59.6M | $62.8M |
| Operating Income | $10.1M | $8.0M | $-22.8M | $18.5M | $-30.0M | $-57.4M | $-27.9M | $5.7M |
| Operating Margin | 10.8% | 8.5% | -39.5% | 19.5% | -67.6% | -134.8% | -57.0% | 6.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $11.0M | $8.2M | $-20.7M | $18.8M | $-25.9M | $-54.5M | $-30.3M | $13.2M |
| Income Tax Expense | $3.0M | $3.0M | $-2.3M | $9.9M | $-9.1M | $-275.0K | $3.9M | $3.2M |
| Net Income | $8.1M | $5.2M | $-18.3M | $8.9M | $-16.8M | $-54.2M | $-34.2M | $10.0M |
| Net Margin | 8.6% | 5.6% | -31.7% | 9.4% | -37.9% | -127.3% | -69.9% | 11.3% |
| EPS (Basic) | $0.16 | $0.10 | $-0.36 | $0.18 | $-0.34 | $-1.10 | $-0.69 | $0.20 |
| EPS (Diluted) | $0.16 | $0.10 | $-0.36 | $0.18 | $-0.34 | $-1.10 | $-0.69 | $0.20 |
| Shares Outstanding (Basic) | 50.3M | 49.9M | 49.6M | 49.6M | 49.5M | 49.3M | 49.1M | 49.2M |
| Shares Outstanding (Diluted) | 51.5M | 50.9M | 49.6M | 50.5M | 49.5M | 49.3M | 49.1M | 49.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |